Nationwide clinical trial of nutritional drink for Alzheimer's

January 25, 2010, Rush University Medical Center

Rush University Medical Center is leading a nationwide clinical trial of a nutritional drink to determine whether it can improve cognitive performance in people with mild to moderate Alzheimer's.

The study follows recently released results from an earlier trial conducted in Europe showing that the drink, called Souvenaid, improved verbal recall in people with mild disease who were followed for three months.

"Our primary goal is to see whether Souvenaid can slow the worsening of memory difficulties in persons with mild to moderate Alzheimer's who are already taking approved treatments for the disease, " said Dr. Raj Shah, medical director of the Rush Memory Clinic and one of the study's lead investigators.

Results of the first European study were released recently following publication in the journal Alzheimer's & . In that study, 225 patients with mild Alzheimer's were divided into two groups. Some drank Souvenaid and the others sipped a non-medical drink every day for 12 weeks.

Researchers found that the patients who drank Souvenaid improved in a delayed verbal recall task.

A total of 500 individuals who are taking medications approved by the U.S. Food and Drug Administration for the symptomatic treatment of mild to moderate will be enrolled in the present study at 40 sites across the U.S. In the double-blinded study, half of the participants will drink about four ounces of Souvenaid once a day for 24 weeks. The other half will drink a control product that is similar in flavor, appearance, and composition, but without the Souvenaid nutrients. Neither group will know whether they are drinking Souvenaid or the other beverage.

Researchers will test whether the participants' cognitive and functional performance — including memory, language, attention/concentration, executive functioning, information processing and recall — shows any greater improvement with Souvenaid than with medication alone.

Related Stories

Recommended for you

Onions could hold key to fighting antibiotic resistance

January 22, 2018
A type of onion could help the fight against antibiotic resistance in cases of tuberculosis, a UCL and Birkbeck-led study suggests.

New long-acting approach for malaria therapy developed

January 22, 2018
A new study, published in Nature Communications, conducted by the University of Liverpool and the Johns Hopkins University School of Medicine highlights a new 'long acting' medicine for the prevention of malaria.

Virus shown to be likely cause of mystery polio-like illness

January 22, 2018
A major review by UNSW researchers has identified strong evidence that a virus called Enterovirus D68 is the cause of a mystery polio-like illness that has paralysed children in the US, Canada and Europe.

Creation of synthetic horsepox virus could lead to more effective smallpox vaccine

January 19, 2018
UAlberta researchers created a new synthetic virus that could lead to the development of a more effective vaccine against smallpox. The discovery demonstrates how techniques based on the use of synthetic DNA can be used to ...

Study ends debate over role of steroids in treating septic shock

January 19, 2018
The results from the largest ever study of septic shock could improve treatment for critically ill patients and save health systems worldwide hundreds of millions of dollars each year.

New approach could help curtail hospitalizations due to influenza infection

January 18, 2018
More than 700,000 Americans were hospitalized due to illnesses associated with the seasonal flu during the 2014-15 flu season, according to federal estimates. A radical new approach to vaccine development at UCLA may help ...

3 comments

Adjust slider to filter visible comments by rank

Display comments: newest first

Caliban
1 / 5 (1) Jan 25, 2010
So, rather than tell the public that drinking a cocktail of easily obtained, cheap ingredients(let's just say, orange juice and green tea, for example) to treat the millions of alzheimer's sufferers, patent a retail-packaged, expensive product to sell at a premium to further exploit income diparities in society. If you can't afford it- you don't deserve it. That's a healthcare model we can all be happy to get behind!
otto1923
not rated yet Jan 25, 2010
http://en.wikiped...ouvenaid
-Ive never seen uridine monophosphate at Vitamin Shoppe but then again Ive never looked for it. Doesnt look like its available anywhere.
Caliban
1 / 5 (1) Jan 26, 2010
http://www.psycho...r-prozac
Otto- you have to be somewhat creative with the search terms, but, according to this article, sugarbeets and molasses are good sources. Dirt cheap. Now, just add some fish oil, blend, and you've got a decent analog of "Souvenaid".

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.